Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bruno Paillard is active.

Publication


Featured researches published by Bruno Paillard.


Drug Development and Industrial Pharmacy | 2013

Extruder scale-up assessment in the process of extrusion-spheronization: comparison of radial and axial systems by a design of experiments approach.

Amélie Désiré; Bruno Paillard; Joel Bougaret; Michel Baron; Guy Couarraze

Scaling-up the extrusion–spheronization process involves the separate scale-up of each of the five process steps: dry mixing, granulation, extrusion, spheronization, and drying. The aim of the study was to compare two screw extrusion systems regarding their suitability for scaling-up. Two drug substances of high- and low-solubility in water were retained at different concentrations as formulation variables. Different spheronization times were tested. The productivity of the process was followed up using the extrusion rate and yield. Pellets were characterized by their size and shape, and by their structural and mechanical properties. A response surface design of experiments was built to evaluate the influence of the different variables and their interactions on each response, and to select the type of extrusion which provides the best results in terms of product quality, the one which shows less influence on the product after scale-up (“scalability”) and when the formula used changes (“robustness”), and the one which allows the possibility to adjust pellet properties with spheronization variables (“flexibility”). Axial system showed the best characteristics in terms of product quality at lab and industrial scales, the best robustness at industrial scale, and the best scalability, by comparison with radial system. Axial system thus appeared as the easiest scaled-up system. Compared to lab scale, the conclusions observed at industrial scale were the same in terms of product quality, but different for robustness and flexibility, which confirmed the importance to test the systems at industrial scale before acquiring the equipment.


Archive | 1997

GALENIC FORMULA WITH EXTENDED RELEASE OF MILNACIPRAN

Bruno Paillard; Eric Goutay; Jean-Louis Avan; Joel Bougaret


Archive | 1997

Pharmaceutical composition with extended release of Milnacipran

Bruno Paillard; Eric Goutay; Jean-Louis Avan; Joel Bougaret


Archive | 2006

Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same

Eric Goutay; Laurence Lachamp; Jacques Frances; Joel Bougaret; Bruno Paillard


Archive | 1997

Forme galenique a liberation prolongee de milnacipran

Bruno Paillard; Eric Goutay; Jean Louis Avan; Joel Bougaret


Archive | 2000

Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention

Eric Goutay; Laurence Lachamp; Jacques Frances; Joel Bougaret; Bruno Paillard


Archive | 2008

Stable pharmaceutical composition of a water-soluble vinorelbine salt

Bruno Paillard; Jean-Louis Avan; Joel Bougaret


Archive | 2008

Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt

Bruno Paillard; Jean Louis Avan; Joel Bougaret


Archive | 2008

Composition pharmaceutique stable comprenant un sel de vinflunine hydrosoluble

Bruno Paillard; Jean Louis Avan; Joel Bougaret


Archive | 2007

A stable pharmaceutical composition of a water soluble salt of vinorelbine.

Bruno Paillard; Jean Louis Avan; Joel Bougaret

Collaboration


Dive into the Bruno Paillard's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge